64
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Post Transplant CD8+ γδ T-Cell Lymphoma Associated with Human Herpes Virus-6 Infection

, , , &
Pages 377-384 | Received 29 May 1998, Published online: 01 Jul 2009

References

  • Morrison V., Dunn D., Manivel J., Gajl‐Peczalska K., Peterson B. Clinical Characteristics of Post‐Transplant Lymphoproliferative Disorders. The American Journal of Medicine 1994; 97: 14–24
  • Borst J., van Dongen J., Bolhuis R., Peters P., Hafler D., de Vries E., van de Griend R. Distinct molecular forms of human T cell receptor γ/δ detected on viable T cells by a monoclonal antibody. Journal of Experimental Medicine 1988; 167: 1625–1644
  • Haas W., Pereira P., Tonegawa S. Gamma/Delta Cells. Annual Review of Immunology 1993; 11: 637–685
  • Wong K., Chan J., Matutes E., McCarthy K., Ng C., Chan C., Ma S. Hepatosplenic γδ T‐cell Lymphoma, a distinctive aggressive lymphoma type. The America Journal of Surgical Pathology 1995; 19: 718–726
  • Penn I., Branson M. Cancers after cyclosporine therapy. Transplantation Proceedings 1988; 20(suppl 3)885–892
  • Penn I. The changing pattern of post‐transplant malignancies. Transplantation Proceedings 1991; 23: 1101–1103
  • Ross C., Schnitzer B., Sheldon S., Braun D., Hanson C. Gamma/Delta T‐Cell Posttransplantation Lymphoproliferative Disorder Primarily in the Spleen. American Journal of Clinical Pathology 1994; 102: 310–315
  • Schild H., Mavaddat N., Litzenberger C., Ehrich E., Davis M., Bluestone J., Matis L., Draper R., Chien Y. The nature of major histocompatibility complex recognition by γδ T cells. Cell 1994; 76: 29–37
  • Mombaerts P., Amoldi J., Russ E., Tonegawa S., Kauf‐mann S. Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen. Nature 1993; 365: 53–56
  • Avinoach I., Halevy S., Argov S., Sacks M. γδ T‐Cell Lymphoma Involving the Subcutaneous Tissue and Associated with a Hemophagocytic Syndrome. The American Journal of Dermatopathology 1994; 16: 426–433
  • Gaulard P., Zafrani E., Mavier P., Rocha F., Farcet J. ‐P., Divine M., Haioun C., Pinaudeau Y. Peripheral T‐cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology 1986; 6: 864–868
  • Gaulard P., Bourquelot P., Kanavaros P., Haioun G., Le Couedic J. ‐P., Divine M., Goossens M., Zafrani E., Farcet J. ‐P., Reyes F. Expression of the alpha/beta and gamma/delta T‐cell receptors in 57 cases of peripheral T‐cell lymphomas, identification of a subset of γ/δ T‐cell lymphomas. American Journal of Pathology 1990; 137: 617–628
  • Farcet J. ‐P., Gaulard P., Marolleau J. ‐P., Le Couedic J. ‐P., Henni T., Gourdin M. ‐F., Divine M., Haioun C., Zafrani S., Goossens M., Hercend T., Reyes F. Hepatosplenic T‐cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T‐cell receptor γδ. Blood 1990; 75: 2213–2219
  • Lin M. ‐T., Shen M. ‐C., Su I. ‐J., Tien H. ‐E., Chen Y. ‐C., Hsu P. ‐N., Chang C. ‐S., Wang C. ‐H. Peripheral T γ/δ lymphoma presenting with idiopathic thrombocytopenic prupura‐like picture. British Journal of Haematology 1991; 78: 280–282
  • Wang C. ‐C., Tien H. ‐E., Lin M. ‐T., Su I. ‐J., Wang C. ‐H., Chuang S. ‐M., Shen M. ‐C., Liu C. ‐H. Consistent presence of isochromosome 7q in hepatosplenic T γδ lymphoma: a new cytogenetic‐clinicopathologic entity. Genes, Chromosomes & Cancer 1995; 12: 161–164
  • Krishnan J., Goodman Z., Frizzera G. Primary hepatic sinusoidal presentation of malignant T cell lymphoma [Abstract]. Modern Pathology 1992; 5: 81
  • Ohno T., Komada E., Yamaguchi M., Oka K., Nishii K., Tsuda M., Katsuta K., Yamaguchi T., Kita K., Shirakawa S. Gamma/delta T‐cell lymphoma with hepatosplenomegaly: report of a case. International Journal of Hematology 1993; 57: 269–276
  • Cooke C. B., Greiner T., Raffeld M., Kingma D., Stetler‐Stevenson M., Jaffe E. γδ T‐Cell Lymphoma: a distinct clinicopathologic entity. Modem Pathology 1994; 7: 106
  • Cooke C. B., Krenacs L., Stetler‐Stevenson M., Greiner T. C., Raffeld M., Kingma D. W., Abruzzo L., Frantz C., Kaviani M., Jaffe E. S. Hepatosplenic T‐cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T‐cell origin. Blood 1996; 88: 4265–4274
  • Mastovich S., Ratech H., Ware R., Moore J., Borowitz M. Hepatosplenic T‐cell lymphoma: an unusual case of a γδ T‐cell lymphoma with a blast‐like terminal transformation. Human Pathology 1994; 25: 102–108
  • Salhany K., Hahn M., Kamoun M., Glick A., Loh E. Hepatosplenic T γδ cell lymphoma: an aggressive cytolytic peripheral T cell lymphoma presenting with severe neutropenia [Abstract]. Modem Pathology 1994; 7: 119
  • Dommann‐Scherrer C., Kurer S., Odermatt B., Dours‐Zim‐mermann M., Heitz J. Occult hepatosplenic T‐γδ lymphoma, Value of genotyping analysis in the differential diagnosis. Virchows Arch 1995; 426: 629–634
  • Garcia‐Sanchez F., Menarguez J., Cristobal E., Cantalejo A., Gil J., Algara R., Vicario J. Hepatosplenic gamma‐delta T‐cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow‐up. British Journal of Haematology 1995; 90: 943–946
  • Garcia‐Sanchez F., Vicario J., Menarguez J., Cristobal E., Cantalejo A., Gil J., Algara R. Hepatosplenic γδ T‐cell Lymphoma. The American Journal of Surgical Pathology 1996; 20: 641–642
  • Keller J., Ansari M., Dawson D., Picker L., McKenna R. Multiparameter Analysis of γδ T‐Cell Lymphoma. Modern Pathology 1997; 128A
  • Sallah S., Smith S. V., Lony L. C. L., Woodard P., Schmitz J. L., Folds J. D. Gamma/delta T‐cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Annals of Hematology 1997; 74: 139–142
  • Guy‐Grand D., Cerf‐Benussan N., Malissen B., Malassis‐Seris M., Briottet C., Vassalli P. Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. Journal of Experimental Medicine 1991; 173: 471–481
  • Burg G., Dummer R., Wilhelm M., Nestle F., Ott M., Feller A., Hefner H., Lanz U. A. S., Wiede J. a Subcutaneous Delta‐Positive T‐Cell Lymphoma that Produces Interferon γ. The New England Journal of Medicine 1991; 325: 1078–1081
  • Wilhelm M., Meyer P., Bartram C., Tony H., Dummer R., Nestle R., Burg G., Wilms K. γδ Receptor‐expressing T‐cell clones from a cutaneous T‐cell lymohoma suppress hematopoiesis. Annals of Hematology 1992; 65: 111–115
  • Gastl G., Huber C. The biology of interferon actions. Blut 1988; 56: 193–199
  • Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpes‐virus‐6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065–1067
  • Razzaque A., Williams O., Wang J., Rhim J. Neoplastic transformation of immortalized human epidermal keratinocytes by two HHV‐6 clones. Virology 1993; 195: 113–120
  • Salahuddin S., Ablashi D., Markham P., Josephs S., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong‐Staal R., Kramarsky B., Gallo R. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596–601
  • Braun D., Hanson C., Kauffman C. Association of human herpesvirus 6 with S100+ chronic lymphoproliferative disease. (Abstract). Clinical Research 1990; 38: 847
  • Hanson C., Bockenstedt P., Schnitzer B., Fox D., Kueck B., Braun D. S100‐Positive, T‐Cell Chronic Lymphoproliferative Disease: An Aggressive Disorder of an Uncommon T‐Cell Subset. Blood 1991; 78: 1803–1813
  • Lyall E., Cubie H. Human herpesvirus‐6 DNA in the saliva of paediatric oncology patients and controls. Journal of Medical Virology 1995; 47: 317–322
  • Piro L., Carrera C., Carson D., Beutler E. Lasting remission in hairy‐cell leukemia induced by a single infusion of 2‐chlorodeoxyadenosine. The New England Journal of Medicine 1990; 322: 1117–1121
  • Estey E., Kurzrock R., Kantarjian H., McCredie K., Beran M., Roller C., Keating M., Hirsch‐Ginsberg C., Huh Y. Treatment of hairy‐cell leukemia with 2‐chlorodeoxyadenosine (2‐CDA). Blood 1992; 79: 882–887
  • O'Brien S., Kurzrock R., Duvic M., Kantarjian H., Stass S., Robertson L., Estey E., Pierce S., Keating M. 2‐Chlorodeoxyadenosine therapy in patients with T‐cell lymphoproliferative disorders. Blood 1994; 84: 733–738
  • Larabe C., Averett D., Paff M., Reardon J., Wilson J., Krenitsky T. 2‐Amino‐6‐methoxypurine arabinoside: an agent for T‐cell malignancies. Cancer Research 1995; 55: 3352–3356

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.